Palatal myoclonus (PM) is a rare disease that may induce dysphagia. Since dysphagia related to PM is unique and is characterized by myoclonic movements of the involved muscles, specific treatments are needed for rehabilitation. However, no study has investigated the treatment effectiveness for this condition. Therefore, the aim of this case report was to describe the benefit of combining behavioral treatment with valproic acid administration in patients with dysphagia triggered by PM. The two cases were treated with combined treatment. The outcomes evaluated by videofluoroscopic swallowing studies before and after the treatment showed significant decreases in myoclonic movements and improved swallowing function. We conclude that the combined treatment was effective against dysphagia related to PM.

Citations

Citations to this article as recorded by  

• Rehabilitation considerations for palato‐pharyngo‐laryngeal myoclonus associated dysphagia
  Cheng‐Chuan Chiang, Ryan Masterson, Eric T Nguyen, Alba Azola
  PM&R.2024; 16(8): 938.     CrossRef
• A Case of Ocular Myoclonus Appearing After Pontine Hemorrhage
  Kenta Uemura, Toru Miwa, Takashi Ono, Kishiko Sunami
  Practica Oto-Rhino-Laryngologica.2024; 117(9): 789.     CrossRef
• Palato-pharyngo-laryngeal myoclonus with recurrent retrograde feeding tube migration after cerebellar hemorrhagic stroke: a case report and review of hypertrophic olivary degeneration
  Jamie L. Fleet, Ronelle Calver, Gihan C. Perera, Zhihui Deng
  BMC Neurology.2020;[Epub]     CrossRef